학술논문
An mTORC1/2 kinase inhibitor enhances the cytotoxicity of gemtuzumab ozogamicin by activation of lysosomal function
Document Type
Article
Author
Source
In Leukemia Research November 2018 74:68-74
Subject
Language
ISSN
0145-2126